Upcoming Event: FGH Academy of Competitive Intelligence Certification Program Chicago October 31-Nov. 4, 2016

Posted by Fuld + Company

Sep 14, 2016 12:10:04 PM

 Join Leonard Fuld, Dr. Ben Gilad, Jan Herring, and Dr. Helen Rothberg, in Chicago October 31-November 4 for their core and advanced certification coursesYou will be engaged, excited, and a bit over whelmed by these dynamic presenters.

Read More

Topics: Competitive Intelligence, Events, FGH Academy of Competitive Intelligence, Fuld, Leonard

Is Amazon Becoming a Bank?

Posted by Ken Sawka

Aug 23, 2016 3:54:49 PM

UPDATE: Wells Fargo and Amazon ended their partnership on 08/31/2016 with minimal comment. The partnership fell under criticism from consumer advocates and organizations promoting affordable education.

Last month, Amazon.com entered the student loan business in a partnership with Wells Fargo, offering lower rates for student loans to Amazon customers who subscribe to the online retailer’s Prime Student service.  Wells Fargo will cut half a percentage point from its interest rate on student loans to Amazon Prime Student members, who also get benefits such as free two-day shipping and access to movies, TV shows, and online photo storage.

Does this deal signal what many have felt is the inevitable entry of technology companies into the financial services industry, or is it a convenient and mutually beneficial partnership between two companies with common interests?

Read More

Topics: Brand Insights, Financial Services, Market Analysis, Competitive Strategy

Upcoming Event: Robert Flynn Speaking at Pharma CI US Conference & Exhibition September 14th

Posted by Fuld + Company

Aug 23, 2016 9:19:47 AM

Join us this month at the Pharma CI Conference & Exhibition taking place September 13th - 14th at the Hilton Parsippany in Parsippany, New Jersey.

The Pharma CI Conference & Exhibition is the largest assembly of senior level pharmaceutical, biotech, and medical device professionals seeking the latest news and the chance to network with all the industry’s luminaries.

Members of our Life Sciences team will be at our booth to find out how we can address your competitive intelligence and strategy development needs in the pharmaceutical, biotech, medical device, and diagnostics industries. Robert Flynn, Principal, Strategic Accounts, will be giving a talk on early warning through scenario planning on Wednesday, September 14th.

Read More

Topics: Competitive Intelligence, Early Warning Monitoring, Fuld + Company, Pharma, Scenario Analysis

Medication-Induced Syndromes Offer Growth Opportunity

Posted by Kyle Nicholson

Aug 15, 2016 1:40:17 PM

Opioid-induced constipation, tardive dyskinesia, and other medication-induced syndromes present worthwhile revenue opportunities for pharmaceutical R&D.

In the 1960s, researchers discovered that the loss of motor control from Parkinson’s disease (PD) was tied to a deficiency of dopamine in a part of the brain involved in the coordination of movement.

Evidence soon established that administration of levodopa, a dopamine precursor molecule, dramatically improved PD symptoms. Here’s the catch: relief of symptoms was accompanied by severe nausea and vomiting. Levodopa was not only being converted to dopamine in the brain but also in the bloodstream, activating dopamine receptors in the peripheral nervous system and causing the adverse side effects.

Read More

Topics: Pharma, Life Sciences, Product Positioning, Competitive Strategy

Can Apple TV Outshine Netflix and Traditional TV Broadcasters?

Posted by Ken Sawka

Aug 3, 2016 11:41:11 AM

Apple has long been expected to “revolutionize” how we watch television.  Ever since it launched Apple TV in 2006, speculation has been rife that Apple would become a major force in video production and distribution.

Apple’s refresh of Apple TV last year - improving voice search with Siri and adding a bunch more apps - did little to quell that speculation.

Read More

Topics: Brand Insights, Innovation, Market Analysis, Technology/Telecomm, Product Positioning, Competitive Strategy

Teva Membership in PhRMA Benefits Brand-Name Pharma

Posted by Steve Ames

Jul 12, 2016 10:53:02 AM

Teva, the world’s largest producer of generic medications, recently requested membership into Pharmaceutical Research and Manufacturers of America (PhRMA), the powerful US trade association of brand-name medicine manufacturers.

PhRMA is a lobby powerhouse, largely due to representation from most of the biggest players in the pharmaceutical industry. As detailed in the New York Times, Teva’s request ruffled the feathers of some PhRMA members who see Teva (and other generics companies) as a threat to the success of branded medicine. Brand-name and generic drug companies are no strangers to court battles against each other, typically around brand patent validity and timelines for generic entrance.

Read More

Topics: Innovation, Pharma, Life Sciences, Competitive Strategy

Of Course Nobody Saw Brexit or Donald Trump Coming

Posted by Ken Sawka

Jul 6, 2016 2:22:24 PM

I recently ran a scenario-based strategic planning engagement with a European online entertainment company. In it, we created five future, plausible scenarios that described what the external operating environment could look like for our client in the next five to seven years. 

In one scenario, the global entertainment industry underwent massive consolidation as technological advances enabled cheap, on-demand entertainment of all sorts that provided the largest entertainment companies an incredible opportunity. In another, trade wars broke out restricting the free flow of intellectual property, leading to a proliferation of “black market” entertainment operations in which shady operators offered products based on questionable access to content. 

Read More

Topics: Competitive Intelligence, Scenario Analysis, Competitive Strategy

Build It, Code It, Test It, Film It: Industrial Content Marketing

Posted by Ola Jachtorowicz

May 12, 2016 1:03:26 PM

When you think of General Electric, what enters your mind? The shine of a lightbulb? The high torque density of laminated salient pole rotors? Or a glowing, hopeful feeling about the ingenuity of the human mind?

If it’s the third option, you’ve been touched by GE’s brand halo. Perhaps a visual even appeared as the halo did its work: pristine wind turbines or young engineers literally catching lightning in a bottle.

Traditionally, the brand halo effect describes how a positive experience with one product can increase purchases of unrelated products from the same brand. Apple is a classic example. The 2005 success of the iPod led to a 27% increase in Apple computer, software, and service sales, despite marketing focusing on the iPod alone.

Here’s the thing: it’s no longer necessary to purchase a product for the brand halo to work its magic, and industrial companies should pay attention. In the price-sensitive and cut-throat markets in which many industrial companies compete, a positive brand halo could be the difference between being a leader and a laggard.

Read More

Topics: Brand Insights, Innovation, Manufacturing/Industrial, Competitive Strategy

New White Paper: Competitive Pricing Intelligence

Posted by Fuld + Company

May 3, 2016 2:36:52 PM

Creating an intelligence gathering and analysis process for your organization’s pricing function is essential for sound competitive strategy. Failure to gather and assess this intelligence can lead to pricing strategies that are out of sync with market expectations.

Our latest white paper outlines legal and ethical considerations that must guide how intelligence is gathered on competitor prices, the advantages of continuous intelligence gathering, and how one client leveraged competitive intelligence to raise prices without losing customers or provoking a competitor response. 

Read More

Topics: Competitive Intelligence, Sales Force Effectiveness, Fuld + Company, Market Analysis, Product Positioning, Competitive Strategy

Physician Heal Thyself: Competitive Strategy Consulting Faces Disruption

Posted by Ken Sawka

Apr 20, 2016 3:28:12 PM

At Fuld + Company, we pride ourselves on giving objective, evidence-based advice on matters of competitive strategy to some of the world’s largest and most innovative companies. But we now potentially find ourselves facing the same sort of competitive disruption that our clients typically call us to help them solve.

Read More

Topics: Competitive Intelligence, Innovation, New Market Entry, Competitive Strategy

Fuld + Company Blog

The material on this page draws on the research and experience of Fuld + Company thought leaders, consultants and others. Learn more about our expertise here.

Request for Information

If you'd like someone at Fuld to contact you regarding your strategic competitive challenges, fill out the form below.